Meet Mirvie’s Team of Health Pioneers

Management

Maneesh Jain, Phd.
Chief Executive Officer
& Co-Founder

Farida Peters-Abbadi, President & Chief Commercial Officer

Farida Peters-Abbadi, Esq.
President & Chief Commercial Officer

Michal Elovitz, M.D.
Chief Medical Advisor

BIOS

Maneesh Jain, Phd. Chief Executive Officer & Co-Founder
Maneesh has been a life science entrepreneur for the past 20+ years, with founding, CEO and executive roles in five previous successful start-ups. Maneesh is passionate about building start-up teams to create innovative products that address large unmet needs in healthcare. His previous experience focused on start-ups that built the very first platforms to create more accessible next generation sequencing and medical ultrasound imaging, as well as the first liquid biopsy plasma test for the early detection of cancer.

Maneesh is currently an independent member of the Board of Directors for Mission Bio and Mammoth Bioscience. He has also served as an executive advisor at several life science companies including Cellular Research, Counsyl, Inscopix, Invitae, Magarray, and NextBio.

Maneesh has degrees from Caltech and Stanford, and trained at the Stanford Genome Technology Center. He is an author on over 20 publications and several patents.

Maneesh's Linked In Profle

Maneesh Jain, Phd.

CEO and Co-founder

“Mirvie has taken a bold and fundamentally different approach to pregnancy health at the molecular level,

Using machine learning analysis of an RNA liquid biopsy, our immediate goal is the early detection of unexpected complications to enable earlier interventions. Down the road we envision that knowledge of the underlying molecular subtypes that drive individual complications will catalyze more effective therapeutic interventions.

I am honored to lead Mirvie with a diverse team of proven leaders and an audacious vision to transform pregnancy health.”

Michal Elovitz, M.D. Chief Medical Advisor
Dr. Elovitz is an internationally known and respected physician-scientist in reproductive, maternal and child health and founder of the successful Maternal and Child Research Center. She currently serves as a Maternal Fetal Medicine specialist in the Department of Obstetrics and Gynecology at the University of Pennsylvania in addition to Vice Chair for Translational Research.

Dr. Elovitz’s current research program has focused on understanding biological underpinnings of adverse pregnancy outcomes, such as preterm birth and preeclampsia, acknowledging the impact of environmental exposures and lived experiences on biological processes.

Dr. Elovitz is an author on over 150 publications, has served on several NIH study sections, is an avid mentor for physician-scientists, and an advocate for women’s health. She co-founded and now directs the Women’s Health Collaborative, an organization that serves to advance equity for women in science and medicine and advances research in women’s health.

Michal's Linked In Profile

Michal Elovitz, M.D.

Chief Medical Advisor

“Mirvie’s precision diagnostic and precision medicine approach has enormous potential to advance health for mothers and their babies. Pregnancy complications affect 60 million women globally each year, 3-4 times the rate of cancer incidence. Yet, little is known about the molecular basis underlying both health and disease for mom and child.

 I’m enthusiastic about the potential to be able to provide a risk-assessment test to mothers that is independent of clinical and demographic factors such as race and body mass index.

Mirvie’s platform holds great promise to reduce these biases in obstetrics.”

Farida Peters-Abbadi, Esq. President & Chief Commercial Officer
With almost 20 years in women’s health, Farida joined Mirvie in 2020 as President & Chief Commercial Officer. Prior to Mirvie, Farida served as Vice President at Renovia, a digital health company focused on developing diagnostics and therapeutics to treat urinary incontinence in women. Farida previously served as the Marketing Director for the prenatal diagnostic and cord blood/tissue stem cell businesses of PerkinElmer Inc. She held various sales and marketing positions at ViaCell Inc. before its acquisition to PerkinElmer.

Farida has extensive experience developing and implementing innovative strategies designed to deliver unified communication and messages to business stakeholders and to promote increases in brand awareness. In addition, Farida brings proven strength building strong teams, and fostering relationships with internal and external stakeholders and business partners through key communication initiatives.

Farida holds two law degrees from McGill University (B.C.L./L.L.B.), a B.A. cum laude from Binghamton University, and an Executive M.B.A. from the Kellogg School of Management at Northwestern University.

Farida's Linked In Profile

Board of Directors

Stanley Lapidus

Stanley Lapidus
Chairman of the Board
view profile

Stephen Quake

Stephen Quake, D.PHIL.
view profile

Naomi Kelman

Naomi Kelman
view profile

Samir Kaul

Samir Kaul
view profile

Ursheet Parikh

Ursheet Parikh
view profile